ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.425
-0.026 (-1.79%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.026 -1.79% 1.425 1.402 1.448 1.42 1.41 1.42 3,614,132 16:35:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -6.69M -0.0059 -2.39 16.1M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.45p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £16.10 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.39.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 251 to 274 of 13425 messages
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older
DateSubjectAuthorDiscuss
27/2/2018
10:24
Chart courtesy of rosolanor https://twitter.com/rosolanor/status/968428429564694529?s=20
leonsito
27/2/2018
09:59
L2 looking like a few more sells will push this further down.
jimmyhoffa262
27/2/2018
09:45
ToptrumpWtfru people dont have to ask u before they buy or sell this is a great company theres nothing wrong with trading the waves i bought at 4 sold at 6 doesnt mean im not confident here nothing goes up in straight line i bought after reading hazl post
mally6
27/2/2018
09:38
As I say I try to be honest.

I am amazed you have the audacity to post here after your embarrassing show yesterday.
You knew absolutely nothing about the company and nothing about me, yet were willing to spout on about both.
Here you are again!

This company was already up when I joined the throng.
It clearly had a break-through and the RNS proved it,completely contrary to your little researched comments!
Look to yourself before you criticise others!

hazl
27/2/2018
09:32
Post 240

hazl26 Feb '18 - 20:48 - 240 of 266
0 1 0
"Only fair to say....having said that I intended to keep them long term....
that I am not keen on the whole chimera thing.
Humanised mice seems wrong to me.
So I won't be posting but I expect the share to continue to do well."




Yeah, right. More like you sold out as I said you would after ramping it all day or even more likely sold after it fell and before the rns without a profit. Such is the whole bulletin board purpose for you short term trading guys (or gambling losers)

Not sure what to make of the rns, I wouldn't invest on principal and even if it were ethical the time to market and huge cash burn that these early stage bios go through prevents any profit for years and years, if at all. Roulette stock.

toptrump1
27/2/2018
09:29
volume has dried up so I think you may have your way on recovery today..watching
tsmith2
27/2/2018
09:29
IMHO a MCAP of £50-60M for a company like HEMO, at this stage, is quite reasonable. Under current shares issued that would give an share price of 15-17p but no doubt you can probably expect rights issues etc before then...... as always DYOR and GLTA
citycanary
27/2/2018
09:16
This will bounce off 5p today.Themms want your stock.The directors are well invested here. I will be disappointed not to see 7p this week

RAMP OVER!!!

billthebank
27/2/2018
09:15
How.much good news can you squeeze into one RBS!!!!!
billthebank
27/2/2018
09:14
Vladislav Sandler, CEO & Co-Founder of Hemogenyx, commented: "We are hugely excited by the first solid data that we've received testing the efficacy of CDX antibodies against Acute Myelogenous Leukemia. The results which show that they can attack and eliminate AML cells is a true breakthrough and a significant development in our process of developing CDX to become a universally available conditioning product for patients undergoing bone marrow transplants as a treatment for serious blood diseases.

"In addition the new type of humanised mice opens the door to extending our work into other disease models and specific drug development which we expect to be of great interest to large biopharmaceutical companies and could form the basis of a number of significant future collaborations."

billthebank
27/2/2018
09:12
First data results have shown that CDX bi-specific antibodies are capable of attacking and eliminating the blood cancer Acute Myelogenous Leukemia (AML) in vitro.
billthebank
27/2/2018
09:11
The Company can confirm that it has filed a provisional patent application relating to the Company's development of a new type of humanised mice with a chimeric mouse-human blood system that can be used to advance product development, as well as for other disease modelling and drug development.
billthebank
27/2/2018
09:10
Lead candidate shown to be effective in treatment of Leukemia
billthebank
27/2/2018
09:09
This will be pushing 7p this week
billthebank
27/2/2018
09:09
Shake.... well done those in profit unlucky to those that are now trapped! Check out BOIL great news just landed, can move very quickly.
oildon11
27/2/2018
09:09
A big shake.Re read the RNS
billthebank
27/2/2018
09:04
A little shake?
tsmith2
27/2/2018
08:14
Well it's up 200% already, so a good trade, good luck if your left in. I wnt risk more at this price.
jimmyhoffa262
27/2/2018
08:12
Shook out the weak traders. .watch this motor now
momentum1
27/2/2018
08:05
I'm out, just in case profit is profit
jimmyhoffa262
27/2/2018
07:36
Pleased for you moormoney........you find us the next !
hazl
27/2/2018
06:42
8p? Think bigger....
babbler
27/2/2018
05:00
Then again, most think that this share is listed on our AIM. Which it is not.
lufc5
27/2/2018
04:58
There has been talk of this potentially getting suspended first thing, due to "the tweet". My take is, would it not have been on the stoke of the rns, or moments before?
lufc5
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older

Your Recent History

Delayed Upgrade Clock